| Title | Molecular Biomedicine |
| Abbreviation | Mol. Biomed. |
| Publication Type | Journal |
| Subject Area, Categories, Scope | Molecular Biology (Q1); Molecular Medicine (Q1) |
| h-index | 25 |
| Overall Rank/Ranking | 1036 |
| SCImago Journal Rank (SJR) | 2.387 |
| Impact Score | 8.41 |
| Publisher | Springer International Publishing |
| Country | Switzerland |
| ISSN | 26628651 |
| Best Quartile | Q1 |
| Coverage History | 2020-2025 |
Molecular Biomedicine is a journal covering the technologies/fields/categories related to Molecular Biology (Q1); Molecular Medicine (Q1). It is published by Springer International Publishing. The overall rank of Molecular Biomedicine is 1036. According to SCImago Journal Rank (SJR), this journal is ranked 2.387. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come. SJR acts as an alternative to the Journal Impact Factor (or an average number of citations received in last 2 years). This journal has an h-index of 25. The best quartile for this journal is Q1.
The ISSN of Molecular Biomedicine journal is 26628651. An International Standard Serial Number (ISSN) is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic. Molecular Biomedicine is cited by a total of 1093 articles during the last 3 years (Preceding 2024).
The Impact IF 2024 of Molecular Biomedicine is 8.41, which is computed in 2025 as per its definition. Molecular Biomedicine IF is increased by a factor of 3.09 and approximate percentage change is 58.08% when compared to preceding year 2023, which shows a rising trend. The impact IF, also denoted as Journal impact score (JIS), of an academic journal is a measure of the yearly average number of citations to recent articles published in that journal. It is based on Scopus data.
Impact IF 2024 of Molecular Biomedicine is 8.41. If the same upward trend persists, Impact IF may rise in 2025 as well.
| Year | Impact IF |
|---|---|
| 2025/2026 | Coming Soon |
| 2024 | 8.41 |
| 2023 | 5.32 |
| 2022 | 3.76 |
| 2021 | 3.05 |
| 2020 | 0.00 |
Molecular Biomedicine has an h-index of 25. It means 25 articles of this journal have more than 25 number of citations. The h-index is a way of measuring the productivity and citation impact of the publications. The h-index is defined as the maximum value of h such that the given journal/author has published h papers that have each been cited at least h number of times.
The ISSN of Molecular Biomedicine is 26628651. ISSN stands for International Standard Serial Number.
An ISSN is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic.
The overall rank of Molecular Biomedicine is 1036. According to SCImago Journal Rank (SJR), this journal is ranked 2.387. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come.
| Year | SJR |
|---|---|
| 2025/2026 | Coming Soon |
| 2024 | 2.387 |
| 2023 | 1.455 |
| 2022 | 1.023 |
| 2021 | |
| 2020 |
| Year | Ranking |
|---|---|
| 2025/2026 | Coming Soon |
| 2024 | 1036 |
| 2023 | 2381 |
| 2022 | 4067 |
| 2021 | 27851 |
| 2020 | 34255 |
Molecular Biomedicine is published by Springer International Publishing. It's publishing house is located in Switzerland. Coverage history of this journal is as following: 2020-2025. The organization or individual who handles the printing and distribution of printed or digital publications is known as Publisher.
Visit the official website of the journal/conference to check the further details about the call for papers.
The IS0 4 standard abbreviation of Molecular Biomedicine is Mol. Biomed.. This abbreviation ('Mol. Biomed.') is well recommended and approved for the purpose of indexing, abstraction, referencing and citing goals. It meets all the essential criteria of ISO 4 standard.
ISO 4 (International Organization for Standardization 4) is an international standard that defines a uniform and consistent system for abbreviating serial publication titles and journals.
If your research field is/are related to Molecular Biology (Q1); Molecular Medicine (Q1), then please visit the official website of this journal.
The acceptance rate/percentage of any academic journal/conference depends upon many parameters. Some of the critical parameters are listed below.
It is essential to understand that the acceptance rate/rejection rate of papers varies among journals. Some Journals considers all the manuscripts submissions as a basis of acceptance rate computation. On the other hand, few consider the only manuscripts sent for peer review or few even not bother about the accurate maintenance of total submissions. Hence, it can provide a rough estimation only.
The best way to find out the acceptance rate is to reach out to the associated editor or to check the official website of the Journal/Conference.
Molecular Biomedicine latest impact IF is 8.41. It's evaluated in the year 2024. The highest and the lowest impact IF or impact score of this journal are 8.41 (2024) and 0.00 (2020), respectively, in the last 5 years. Moreover, its average IS is 4.11 in the previous 5 years.
The Molecular Biomedicine has an SJR (SCImago Journal Rank) of 2.387, according to the latest data. It is computed in the year 2025. In the past 5 years, this journal has recorded a range of SJR, with the highest being 2.387 in 2024 and the lowest being in 2021. Furthermore, the average SJR of the Molecular Biomedicine over the previous 5-year period stands at 4.11.
The latest h-index of the Molecular Biomedicine is 25.
The Molecular Biomedicine is published by the Springer International Publishing, with its country of publication being the Switzerland.
The Molecular Biomedicine is currently ranked 1036 out of 27955 Journals, Conferences, and Book Series in the latest ranking. Over the course of the last 5 years, this journal has experienced varying rankings, reaching its highest position of 1036 in 2024 and its lowest position of 34255 in 2020.
The standard ISO4 abbreviation for the Molecular Biomedicine is Mol. Biomed..
Molecular Biomedicine is classified as a journal that the Springer International Publishing publishes.
The Molecular Biomedicine encompasses the following areas:
For a more comprehensive understanding of its scope, check the official website of this journal.
The Molecular Biomedicine is assigned the following International Standard Serial Numbers (ISSN): 26628651.
The best quartile for the Molecular Biomedicine is Q1 (2024).
The Molecular Biomedicine coverage history can be summarized as follows: 2020-2025.
| Journal/Conference/Workshop/Book Title | Type | Ranking | Publisher | h-index | Impact Score |
|---|---|---|---|---|---|
| Indian Journal of Plastic Surgery | journal | 30965 | Georg Thieme Verlag | 44 | 0.46 |
| Analysis in Theory and Applications | journal | 19346 | Springer Netherlands | 11 | 0.00 |
| Entrepreneurship Theory and Practice | journal | 168 | SAGE Publications Ltd | 212 | 13.35 |
| Mathematical Modelling and Analysis | journal | 9616 | Vilnius Gediminas Technical University | 31 | 1.49 |
| Child and Family Social Work | journal | 8793 | Wiley-Blackwell Publishing Ltd | 78 | 2.42 |
| Socialism and Democracy | journal | 27160 | Taylor and Francis Ltd. | 19 | 0.20 |
| Syntax | journal | 2676 | Wiley-Blackwell Publishing Ltd | 35 | 1.10 |
| Transnational Corporations | journal | 13970 | UNCTAD United Nations Conference on Trade and Development | 30 | 1.63 |
| Indian Phytopathology | journal | 16772 | Springer | 20 | 0.91 |
| Oral Radiology | journal | 9860 | Springer Japan | 28 | 2.17 |
| Year | Impact Score (IS) |
|---|---|
| 2025/2026 | Coming Soon |
| 2024 | 8.41 |
| 2023 | 5.32 |
| 2022 | 3.76 |
| 2021 | 3.05 |
| 2020 | 0.00 |
